AI expert and entrepreneur Priya Dialani relates to The Yuan how Fujitsu Research is making healthcare more effective with AI, especially in cancer treatments. Genomic medicine and therapies - AI-driven individualized treatments based on individuals’ unique genomic sequences - also hold huge potential for breakthroughs.

The Yuan recently spoke with Dr Georgios S. Stamatakos, father of in-silico medicine, research professor at the National Technical University of Athens, and director of the In-Silico Oncology and In-Silico Medicine Group of ICCS-SECE-NTUA, to find out about this fascinating scientific field.

Anastasia Georgievskaya is doing important work for the longevity revolution, using AI to develop biomarkers from photos of consumers’ skin. Ironically, consumers seem more interested in offers of enhanced attractiveness than of extended lifespan.

Calum Chace examines how Sergey Young, a longevity leader, is funding research to help humans live longer, healthier, and more productive lives, with artificial intelligence and other new technologies potentially expanding the limits of what is currently possible. Will it soon become possible for humans to halt or even reverse aging, and if so, what would be the ethical ramifications of such an outcome?

In an exclusive interview with The Yuan, Lifespark Chief Executive Officer Joel Theisen spoke with Oladimeji Ewumi, and shared insights on how the company is leveraging artificial intelligence to help aging populations live healthier and longer.